Table 1.
Study population (n = 33) | |
---|---|
Gender (Male/ Female) | 17/16 |
Age (year) (mean ± SD) | 56.36 ± 12.29 |
COVID-19 severity (%) | |
Moderate | 18 (54.5%) |
Severe | 15 (45.5%) |
Patients with medical conditions (%) | 21 (63.6%) |
Co-existing medical conditions (%) | |
Hypertension | 11 (33.3%) |
Diabetes | 8 (24.2%) |
Coronary artery disease | 4 (12.1%) |
Haematological disease | 2 (6.1%) |
Benign prostatic hyperplasia | 3 (9.1%) |
Thyroid disease | 2 (6.1%) |
Chronic heart failure | 1 (3%) |
Arrythmia | 1 (3%) |
Chronic gastrointestinal disease | 2 (4%) |
Signs and symptoms at admission (%) | |
High body temperature | 25 (75.8%) |
Malaise (fatigue) | 22 (66.7%) |
Tachycardia | 20 (60.6%) |
Cough | 17 (51.5%) |
Dyspnoea | 15 (45.5%) |
Loss of appetite | 5 (15.2%) |
Nausea | 4 (12.1%) |
Myalgia | 3 (9.1%) |
Headache | 2 (6.1%) |
Diarrhoea | 2 (6.1%) |
Rhinorrhea | 1 (3.0%) |